Reactogenicity of COVID-19 Vaccines in Young Children: Generally Mild in CDC Study Introduction: The Need for Evidence on Pediatric COVID-19 Vaccination Reactions The COVID-19 pandemic reshaped public health discourse worldwide,
Tag: Vaccine
COVID-19 Vaccine Hesitancy in the U.S.: Trends and Implications A Pew Research Center survey published October 2024 reveals that 60% of Americans are unlikely to receive the updated COVID-19 vaccine
How Self-Rated Health and Vaccine History Influence MPOX Vaccine Acceptance: A Study in Ghana The recent outbreak of monkeypox (MPOX) has highlighted the importance of understanding factors that drive vaccine
Top 5 Takeaways Increased Protection with Boosters: Additional primary or booster COVID-19 vaccine doses significantly enhance protection against the Omicron variant in nursing home residents, showing a relative vaccine effectiveness
Top 5 Takeaways New Vaccine Option: JYNNEOS, a replication-deficient Vaccinia virus vaccine licensed in 2019, is now recommended by ACIP for preexposure prophylaxis against orthopoxviruses, offering an alternative to ACAM2000.
Top 5 Takeaways New Vaccine Approval: The FDA has approved the Pfizer Pentavalent Meningococcal Vaccine (MenACWY-TT/MenB-FHbp, branded as Penbraya) for individuals aged 10–25 years to protect against serogroups A, B,
Top 5 Takeaways Initial Disparities in Vaccination Coverage: Early in the vaccination campaign, Asian and non-Hispanic White adults had the highest COVID-19 vaccination coverage, while coverage was lower among Hispanic,
Top 5 Takeaways Low incidence of sudden cardiac death post-vaccination: Among 1,292 deaths of Oregon residents aged 16–30 during the study period, only three sudden deaths occurred within 100 days
Top 5 Takeaways Significant Increase in Vaccine Supply: From 2021 to 2023, COVID-19 vaccine doses received in the African Region increased from 321 million to 860 million, with 646 million
Top 5 Takeaways Novel OPV2 Shows Genetic Stability: Global genomic surveillance confirms the genetic stability of the novel oral poliovirus vaccine type 2 (nOPV2), maintaining the primary attenuating site’s integrity